Potential Diagnostic and Prognostic Values of CBX8 Expression in Liver Hepatocellular Carcinoma, Kidney Renal Clear Cell Carcinoma, and Ovarian Cancer: A Study Based on TCGA Data Mining

Figure 5

Analysis of genetic alteration and somatic mutation in CBX8 in LIHC, KIRC and OV. (a) OncoPrint visual summary of alteration on a query of CBX8. (b) Summary of alterations in CBX8 in LIHC, KIRC, and OV from TCGA. (c) Altercation frequency of CBX8 of LIHC, KIR, and OV cancers. (d) The somatic mutation rate of CBX8 across LIHC. (e) The somatic mutation rate of CBX8 across KIRC. (f) The somatic mutation rate of CBX8 across OV. Kaplan–Meier plots comparing (g) OS and (h) disease-free survival in patients with/without CBX8 gene alterations.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)